Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Arexvy vaccine powder and suspension for suspension for injection 0.5ml vials (GlaxoSmithKline UK Ltd) |
| BNF code | 1404000AWBBAAAA |
| Virtual Medicinal Product | Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted) powder and suspension for suspension for injection 0.5ml vials |
| Name | Arexvy vaccine powder and suspension for suspension for injection 0.5ml vials |
| Abbreviated name | Arexvy vaccine inj 0.5ml vials |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Arexvy vaccine powder and suspension for suspension for injection 0.5ml vials (GlaxoSmithKline UK Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_3.1.0_20250310000001, imported on 11th March 2025 at 03:57:45.